Adherence to the Mediterranean Diet, Dietary Patterns and Body Composition in Women with Polycystic Ovary Syndrome (PCOS)

被引:163
|
作者
Barrea, Luigi [1 ]
Arnone, Angela [1 ]
Annunziata, Giuseppe [2 ]
Muscogiuri, Giovanna [1 ]
Laudisio, Daniela [1 ]
Salzano, Ciro [1 ]
Pugliese, Gabriella [1 ]
Colao, Annamaria [1 ]
Savastano, Silvia [1 ]
机构
[1] Univ Naples Federico II, Med Sch Naples, Dipartimento Med Clin & Chirurg, Unit Endocrinol, Via Sergio Pansini 5, I-80131 Naples, Italy
[2] Univ Naples Federico II, Dept Pharm, Via Domenico Montesano 49, I-80131 Naples, Italy
关键词
Mediterranean Diet; Dietary pattern; Body Composition; Phase Angle; Polycystic Ovary Syndrome (PCOS); Nutritionist; BIOELECTRICAL-IMPEDANCE ANALYSIS; POPULATION REFERENCE VALUES; PHASE-ANGLE; INSULIN-RESISTANCE; CLINICAL SEVERITY; OLIVE OIL; FAT; INFLAMMATION; GROWTH; MASS;
D O I
10.3390/nu11102278
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Polycystic ovary syndrome (PCOS) is the most common female endocrine disorder and is characterized by chronic anovulation, hyperandrogenism, and polycystic ovaries. Obesity, low-grade chronic inflammatory status, and insulin-resistance (IR) often coexist in PCOS. The Mediterranean diet (MD) is an anti-inflammatory dietary pattern, which is rich in complex carbohydrates and fiber, and high in monounsaturated fat. There is a close association among obesity, low-grade chronic inflammation, IR, and hormonal derangements in PCOS. The main aim of the present study was to evaluate the adherence to MD, the dietary intake, and the body composition and their association with PCOS clinical severity in a cohort of treatment-naive women with PCOS when compared with a control group of healthy women matched for age and body mass index (BMI). In this case-controlled, cross-sectional study, we enrolled 112 patients with PCOS and 112 controls. PREvencion con DIetaMEDiterranea (PREDIMED) and seven-day food records were used to evaluate the degree of adherence to the MD and dietary pattern, respectively. Body composition was evaluated by bioelectrical impedance analysis (BIA) phase-sensitive system. Testosterone levels and Ferriman-Gallwey score assessed the clinical severity of PCOS. C-reactive protein (CRP) levels were determined with a nephelometric assay with CardioPhase high sensitivity. PCOS women showed higher testosterone levels, Ferriman-Gallwey score, fasting insulin and glucose levels, and Homeostatic Model Assessment (HoMA)-IR when compared with the control group (p < 0.001). In addition, we found that the PCOS women consumed less extra-virgin olive oil, legumes, fish/seafood, and nuts compared with control group. Despite no differences in energy intake between the two groups, the PCOS women consumed a lower quantity of complex carbohydrate, fiber, monounsaturated fatty acids (MUFA), and n-3 polyunsaturated fatty acid (PUFA), and higher quantity of simple carbohydrate, total fat, saturated fatty acid (SFA), PUFA and n-6 PUFA than the control group. The PCOS women have an adverse body composition when compared with controls, with the lowest values of phase angle (PhA) and fat-free mass (p < 0.001). Additionally, after adjusting for BMI and total energy intake, testosterone levels showed significant negative correlations with PREDIMED score (p < 0.001) and consumption of protein (p = 0.005), complex carbohydrate (p < 0.001), fiber (p < 0.001), MUFA (p < 0.001), n-3 PUFA (p = 0.001), and positive associations with CRP levels, simple carbohydrate, SFA, n-6 PUFA (p < 0.001, respectively), and PUFA (p = 0.002). The cut-off for PREDIMED score <= 6 (p < 0.001, area under the curve (AUC) 0.848, standard error 0.036, 95% confidence interval (CI) 0.768 to 0.909) could serve as a threshold for significantly increased risk of high value of testosterone levels. In conclusion, a novel direct association between the adherence to MD and the clinical severity of the disease was reported in women with PCOS. This association could support a therapeutic role of foods and nutrients of the Mediterranean dietary pattern in the PCOS pathogenesis likely involving their inflammatory status, IR, and hyperandrogenemia. In addition, we reported a different body composition that is characterized by lower PhA and fat-free mass than controls. These data suggested a role of PhA as a useful marker of the clinical severity of this syndrome and provided strong evidence regarding the strategic relevance of the nutritional assessment in the management of women with PCOS.
引用
下载
收藏
页数:21
相关论文
共 50 条
  • [31] Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome
    Kirchengast, S
    Huber, J
    HUMAN REPRODUCTION, 2001, 16 (06) : 1255 - 1260
  • [32] BODY COMPOSITION OF INDIVIDUALS WITH POLYCYSTIC OVARY SYNDROME
    De Nicola, Fabiana
    Pepe, Ilenia
    Agrusa, Antonio
    Cusumano, Gaspare
    Bucchieri, Salvatore
    Scozzari, Francesca
    Adragna, Floriana
    Gaglio, Edy Costanza
    Foraci, Anna Carola
    Giammanco, Antonina
    Vassallo, Laura
    Gulotta, Gaspare
    Carmina, Enrico
    ACTA MEDICA MEDITERRANEA, 2009, 25 (01): : 11 - 17
  • [33] Effects of a high-protein diet versus a normal-protein diet on body weight and body composition in women with polycystic ovary syndrome
    Sorensen, L. B.
    Christoffersen, M. S.
    Halkier, K. H.
    Stigsby, B.
    Kreutzer, M.
    Pedersen, U.
    Astrup, A.
    INTERNATIONAL JOURNAL OF OBESITY, 2008, 32 : S87 - S87
  • [34] Impact of body mass index and polycystic ovary syndrome (PCOS) subtypes on periodontal health in Chinese women with PCOS and periodontitis
    Liu, Xiaodan
    Wang, Fengran
    Wang, Xiao
    Luan, Qingxian
    GYNECOLOGICAL ENDOCRINOLOGY, 2024, 40 (01)
  • [35] Reconsidering the Polycystic Ovary Syndrome (PCOS)
    Gleicher, Norbert
    Darmon, Sarah
    Patrizio, Pasquale
    Barad, David H.
    BIOMEDICINES, 2022, 10 (07)
  • [36] Polycystic ovary syndrome (PCOS) in adolescence
    Ibanez, L
    HUMAN REPRODUCTION, 2005, : 301 - 305
  • [37] Genotyping in polycystic ovary syndrome (PCOS)
    Spinner, DM
    Babbel, B
    Schulze, E
    Geisthövel, F
    IFFS 2001 SELECTED FREE COMMUNICATIONS, 2001, : 311 - 314
  • [38] Polycystic ovary syndrome (PCOS) in adolescence
    Strowitzki, T.
    GYNAKOLOGISCHE ENDOKRINOLOGIE, 2005, 3 (03): : 161 - 166
  • [39] Inositol for Polycystic Ovary Syndrome (PCOS)
    Seifert-Klauss, Vanadin
    GYNAKOLOGISCHE ENDOKRINOLOGIE, 2024, 22 (03): : 230 - 232
  • [40] Polycystic ovary syndrome (PCOS) in adolescence
    Ibáñez, L
    PROCEEDINGS OF THE 12TH INTERNATIONAL CONGRESS OF ENDOCRINOLOGY, 2004, : 169 - 173